News about "European Union"

EU Approves KEYTRUDA for PD-L1+ Resectable Head and Neck Cancer

EU Approves KEYTRUDA for PD-L1+ Resectable Head and Neck Cancer

KEYTRUDA monotherapy has been approved for use as a neoadjuvant treatment, followed by adjuvant therapy in combination with radiotherapy with or without cisplatin, and continued thereafter as maintenance monotherapy.

European Union | 30/10/2025 | By Dineshwori

Dr. Reddy's Receives Positive CHMP Opinion from European Medicines Agency for Denosumab

Dr. Reddy's Receives Positive CHMP Opinion from European Medicines Agency for Denosumab

Dr. Reddy’s Laboratories has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for AVT03, a proposed biosimilar to Prolia and Xgeva, moving it closer to potential marketing authorisation in the European Economic Area (EEA).

European Union | 24/09/2025 | By Dineshwori

CHMP Recommends T-DXd EU Approval in HER2-Low/Ultralow Breast Cancer

CHMP Recommends T-DXd EU Approval in HER2-Low/Ultralow Breast Cancer

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.

European Union | 04/03/2025 | By Aishwarya 188

Bio-Thera's BAT2506 Biosimilar to Simponi Gains EMA Review for EU Approval

Bio-Thera's BAT2506 Biosimilar to Simponi Gains EMA Review for EU Approval

The reference medicine golimumab has been approved in Europe for several indications including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis.

European Union | 07/02/2025 | By Abha 321

Evergreen Theragnostics Opens Phase II Small Cell Lung Cancer Clinical Trial in EU

Evergreen Theragnostics Opens Phase II Small Cell Lung Cancer Clinical Trial in EU

The CCK2-VIEW trial uses 68Ga-EVG321, a peptide-based Radioligand imaging agent administered to patients with small cell lung cancer.

European Union | 18/10/2024 | By Aishwarya 346

Union Health Secretary Explores Vaccine Collaboration at Bilthoven Biologicals in Netherlands

Union Health Secretary Explores Vaccine Collaboration at Bilthoven Biologicals in Netherlands

The focus centered on enhancing partnership and cooperation in the production of vaccines, addressing critical issues related to pandemic preparedness.

European Union | 29/04/2024 | By Abha 263


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members